684 related articles for article (PubMed ID: 8768488)
1. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
2. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
3. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
4. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
[TBL] [Abstract][Full Text] [Related]
5. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections.
Zhang L; Tarleton RL
Exp Parasitol; 1996 Nov; 84(2):203-13. PubMed ID: 8932770
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
7. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
Fernandez-Gomez R; Esteban S; Gomez-Corvera R; Zoulika K; Ouaissi A
J Immunol; 1998 Apr; 160(7):3471-9. PubMed ID: 9531308
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production.
Zhang L; Tarleton RL
Eur J Immunol; 1996 Jan; 26(1):102-9. PubMed ID: 8566051
[TBL] [Abstract][Full Text] [Related]
10. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A
Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
12. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase.
Guedes PM; Veloso VM; Afonso LC; Caliari MV; Carneiro CM; Diniz LF; Marques-da-Silva EA; Caldas IS; Do Valle Matta MA; Souza SM; Lana M; Chiari E; Galvão LM; Bahia MT
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):43-52. PubMed ID: 19211152
[TBL] [Abstract][Full Text] [Related]
13. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
[TBL] [Abstract][Full Text] [Related]
14. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
Abrahamsohn IA; Coffman RL
J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
[TBL] [Abstract][Full Text] [Related]
15. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
[TBL] [Abstract][Full Text] [Related]
16. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
18. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi.
Bombeiro AL; D'Império Lima MR; Chadi G; Alvarez JM
Neuroimmunomodulation; 2010; 17(2):67-78. PubMed ID: 19923851
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM
Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]